Patrick Vallance

Last updated

Sir

Patrick Vallance

KCB FRS FMedSci FRCP HonFREng
Patrick Vallance Royal Society (cropped).jpg
Patrick Vallance at the Royal Society admissions day in London, July 2017
Born
Patrick John Thompson Vallance

(1960-03-17) 17 March 1960 (age 63) [1]
Essex, United Kingdom
Education Truro School
Alma mater St George's, University of London (BSc, MBBS)
Spouse
Sophia Ann Dexter
​
(m. 1986)​
[1]
Children3
Awards Goulstonian Lecture (1996) [2]
Royal Medal (2023)
Scientific career
Institutions
Website www.gov.uk/government/people/patrick-vallance

Sir Patrick John Thompson Vallance KCB FRS FMedSci FRCP HonFREng (born 17 March 1960 [1] ) is a British physician, scientist, and clinical pharmacologist who has worked in both academia and industry. He served as the Chief Scientific Adviser to the Government of the United Kingdom from 2018 to 2023. On stepping down, he became chair of the Natural History Museum in London. [3]

Contents

From 1986 to 1995, Vallance taught at St George's Hospital Medical School, where his research concentrated on vascular biology and endothelial cell physiology. In 1995, he was appointed Professor at UCL Medical School, and in 2002 he became head of UCL's Department of Medicine. From 2012 to 2018, he was president of Research and Development at global pharmaceutical company GlaxoSmithKline (GSK). [4]

Early life and education

Patrick Vallance was born on 17 March 1960 to Peter and Barbara Vallance, in south-west Essex, now part of Greater London. [1] Before his family moved to Cornwall he was educated at Woodford Green Preparatory School and Buckhurst Hill County High School. Subsequently he was educated at the independent Truro School and his early aspiration was to become a palaeontologist. [5]

In 1978, Vallance gained admission to study medicine at St George's, University of London, where he was taught by Joe Collier, Professor of Medicines Policy, [2] [5] [6] and from where he received a Bachelor of Science degree in 1981 followed by a Bachelor of Medicine, Bachelor of Surgery (MBBS) in 1984. [1] In addition to Collier, he has been inspired by physician Tom Pilkington and former Regius Professor of Physic at Cambridge, Sir Keith Peters. [5]

Career and research

Prior to taking up senior positions with the pharmaceutical company GlaxoSmithKline (GSK) and later in the UK Government, Vallance spent several years in medical research. [7]

St George's Hospital

From 1986 to 1995 he taught at St George's Hospital Medical School, [1] [6] where his research concentrated on vascular biology and endothelial cell physiology. [8] [9] Prior to the discovery of the involvement of nitric oxide, it was believed that high blood pressure was usually a result of constrictor activity in blood vessels. Vallance performed studies which demonstrated the link between nitric oxide and blood pressure. [10]

In 1987, with Joe Collier, he set out to investigate whether human blood vessels demonstrated endothelium-dependent relaxation, a term coined in 1980 by Robert F. Furchgott and John V. Zawadzki after discovering that a large blood vessel would not relax when its single-layered inner most lining was removed. Furchgott and Zawadzki subsequently showed that the occurrence was mediated by what they called endothelium-derived relaxing factor, later found to be nitric oxide, and it was shortly shown to occur in a variety of animals. Using veins from the back of a human hand, Vallance and Collier reproduced Furchgott and Zawadzki's findings. [2] [11] Subsequently, their team showed that the human arterial vasculature is actively dilated by a continuous release of nitric oxide. [9] [12] In 1991, Vallance and Salvador Moncada published a paper on the role of nitric oxide in cirrhosis, proposing an association between the changes in blood flow in cirrhosis and the vasoactive properties of nitric oxide. [13] The following year they reported that the plasma concentrations of asymmetric dimethylarginine (ADMA) were elevated in people who were uraemic. [14] [15]

University College Hospital

From 1995 to 2002 he was a professor at UCL Medical School, then Professor of Medicine from 2002 to 2006, and head of medicine. [1] [16] He was also registrar of the Academy of Medical Sciences. [9] In 2005, as head of the division of medicine at UCL, he published a paper in the Journal of the Royal Society of Medicine , titled "A post-take ward round", in which he suggested that "reinvention of teams of doctors, nurses, therapists and social workers seems like an important task for general medicine". [17] [18] [19]

GlaxoSmithKline

In 2006, in his mid-40s, he joined GSK as head of drug discovery. [20] [21] Four years later he became head of medicines discovery and development, and in 2012 he was appointed head of research and development at GSK. [22] [23] [24] [25] [26] Under his leadership, new medicines for cancer, asthma, autoimmune diseases and HIV infection were discovered and approved for use worldwide. He championed open innovation and novel industry-academic partnerships globally, [9] [27] [25] and maintained a focus on the search for new antibiotics and treatments for tropical diseases. [9] [28]

UK Government

Vallance in a British Government photograph; a ministerial red box is in the background at left Dr Patrick Vallance.jpg
Vallance in a British Government photograph; a ministerial red box is in the background at left

In March 2018, Vallance left GSK, and on 4 April 2018 he began his five-year tenure as Chief Scientific Adviser to the UK Government, replacing the interim officeholder Chris Whitty. [29] In this role he led the Government Office for Science, advising the prime minister and the cabinet. [30] [31] In 2018, he was one of nine scientific advisers who, in a paper in Nature , called for "inclusive, rigorous, transparent, and accessible information for policy makers" and supported the Evidence-Based Research Network, established in 2016, to "lobby for all proposals for new research to be supported by references to systematic reviews of relevant existing research". [32]

COVID-19 pandemic

In March 2020, as the government's Chief Scientific Adviser, Vallance appeared alongside prime minister Boris Johnson and the Chief Medical Officer for England, Chris Whitty, in televised briefings on the COVID-19 pandemic. [33] [34] For a time, he advocated a herd immunity approach. [35]

In September, it emerged that Vallance owns a deferred bonus of 43,111 shares worth £600,000 in GlaxoSmithKline, a company which is working on developing a COVID vaccine. [36] This led to claims of a potential conflict of interest, as Vallance could be seen to have a financial interest in pushing for a vaccine-based response to the pandemic whether or not this is objectively the best approach. [37] Then Health Secretary Matt Hancock denied that this was the case, with a government spokesperson stating that, "Upon his appointment, appropriate steps were taken to manage the Government Chief Scientific Adviser's interests in line with advice provided at the time. The GCSA has no input into contractual and commercial decisions on vaccine procurement which are taken by Ministers following a robust cross-Government approvals regime". [38]

After a televised briefing alongside Johnson and Whitty on 31 October, where a second "lockdown" was introduced for England, Vallance was criticised for showing two slides – projecting hospital admissions and deaths – which were later reissued with worst-case figures revised downward. [39] [40] [41] Five days later, a statement from the Office for Statistics Regulation called for greater transparency in published data relating to the pandemic, including publication of data sources and modelling assumptions; the statement did not refer to any specific presentation but was linked by reporters to the 31 October briefing. [42] [43]

Selected publications

His publications [8] include:

Honours and awards

In 1995, Vallance was elected a Fellow of the Royal College of Physicians (FRCP). [1] The following year he delivered the Goulstonian Lecture of the College, where he gave details of the connection between nitric oxide and blood pressure. [49] In 1999 he was elected a Fellow of the Academy of Medical Sciences (FMedSci), and in 2002 he was awarded the Graham Bull Prize for Clinical Science. [9] He was elected a Fellow of the Royal Society (FRS) in 2017 [9] and an Honorary Fellow of the Royal Academy of Engineering (HonFREng) in 2022. [50]

Vallance was knighted in the 2019 New Year Honours. [51] He was appointed Knight Commander of the Order of the Bath (KCB) in the 2022 New Year Honours for services to science in government. [52] [53] In 2023 he was awarded the Royal Medal of the Royal Society. [54]

Personal life

Vallance married Sophia Ann Dexter in 1986; they have two sons and one daughter. [1] Dexter is a former general practitioner (GP) and honorary tutor at St. George's Hospital Medical School. [55]

Related Research Articles

<span class="mw-page-title-main">Robert F. Furchgott</span> American biochemist (1916–2009)

Robert Francis Furchgott was a Nobel Prize-winning American biochemist who contributed to the discovery of nitric oxide as a transient cellular signal in mammalian systems.

<span class="mw-page-title-main">Salvador Moncada</span> Honduran pharmacologist and professor

Sir Salvador Enrique Moncada Seidner, FRS, FRCP, FMedSci is a Honduran pharmacologist and professor. He is currently Research Domain Director for Cancer at the University of Manchester.

The UK Government Chief Scientific Adviser (GCSA) is the personal adviser on science and technology-related activities and policies to the Prime Minister and the Cabinet. They are also the head of the Government Office for Science.

The Journal of the Royal Society of Medicine is a peer-reviewed medical journal. It is the flagship journal of the Royal Society of Medicine with full editorial independence. Its continuous publication history dates back to 1809. Since July 2005 the editor-in-chief is Kamran Abbasi, who succeeded Robin Fox who was editor for almost 10 years.

<span class="mw-page-title-main">Angela McLean (biologist)</span> British Professor of Mathematical Biology

Dame Angela Ruth McLean is professor of mathematical biology in the Department of Biology, University of Oxford, and Chief Scientific Adviser to the UK Government.

<span class="mw-page-title-main">Mark Walport</span> English medical scientist and immunologist

Sir Mark Jeremy Walport is an English medical scientist and was the Government Chief Scientific Adviser in the United Kingdom from 2013 to 2017 and Chief Executive of UK Research and Innovation (UKRI) from 2017 to 2020. In 2023 he became the Foreign Secretary of The Royal Society.

<span class="mw-page-title-main">Jeremy Farrar</span> British medical researcher

Sir Jeremy James Farrar is a British medical researcher who has served as Chief Scientist at the World Health Organization since 2023. He was previously the director of The Wellcome Trust from 2013 to 2023 and a professor of tropical medicine at the University of Oxford.

Joseph Gavin Collier is a British retired clinical pharmacologist and emeritus professor of medicines policy at St George's Hospital and Medical School in London, whose early research included establishing the effect of aspirin on human prostaglandins and looking at the role of nitric oxide and angiotensin converting enzyme in controlling blood vessel tone and blood pressure. Later, in his national policy work, he helped change the way drugs are priced and bought by the NHS, and ensured that members of governmental advisory committees published their conflicts of interest.

Paul-Peter Tak M.D. PhD FMedSci is an immunologist and academic specialising in the fields of internal medicine, rheumatology and immunology. Tak has been the President & CEO of Candel Therapeutics since September 2020.

John Richard Seale was a British venereologist and advocate in the 1980s of the now-discredited theory that HIV which causes AIDS might have been created in a germ-warfare laboratory by gene-editing. His views and writings were subsequently used to back-up the claims of those that proposed a man-made origin for the virus, and in Soviet propaganda against the United States. A collection of papers relating to Seale's views on HIV are held by the Wellcome Collection.

<span class="mw-page-title-main">Chris Whitty</span> British physician and epidemiologist (born 1966)

Sir Christopher John MacRae Whitty is a British epidemiologist, serving as Chief Medical Officer for England and Chief Medical Adviser to the UK Government since 2019.

A respiratory syncytial virus vaccine, or RSV vaccine, is a vaccine that protects against respiratory syncytial virus. RSV affects an estimated 64 million people and causes 160,000 deaths worldwide each year.

The Scientific Advisory Group for Emergencies (SAGE) is a British Government body that advises central government in emergencies. It is usually chaired by the United Kingdom's Chief Scientific Adviser. Specialists from academia and industry, along with experts from within government, make up the participation, which will vary depending on the emergency. SAGE gained public prominence for its role in the 2020 COVID-19 pandemic in the United Kingdom.

<span class="mw-page-title-main">Jonathan Van-Tam</span> British public health physician

Sir Jonathan Stafford Nguyen Van-Tam is a British healthcare professional specialising in influenza, including its epidemiology, transmission, vaccinology, antiviral drugs and pandemic preparedness.

<span class="mw-page-title-main">Moncef Slaoui</span> Moroccan-American-Belgian doctor and researcher

Moncef Mohamed Slaoui is a Moroccan-born Belgian-American researcher who served as the head of Operation Warp Speed (OPWASP) under President Donald Trump from 2020 to 2021.

<span class="mw-page-title-main">Vaccine Taskforce</span> Non-departmental body coordinating efforts to introduce a COVID-19 vaccine

The Vaccine Taskforce in the United Kingdom of Great Britain and Northern Ireland was set up in April 2020 by the Second Johnson ministry, in collaboration with Chief Scientific Advisor Patrick Vallance and Chief Medical Officer Professor Chris Whitty, in order to facilitate the path towards the introduction of a COVID-19 vaccine in the UK and its global distribution. The taskforce coordinated the research efforts of government with industry, academics and funding agencies in order to expedite vaccine development and deployment.

<span class="mw-page-title-main">Shabir Madhi</span> South African physician and professor

Shabir Ahmed Madhi, is a South African physician who is professor of vaccinology and director of the South African Medical Research Council Respiratory and Meningeal Pathogens Research Unit at the University of the Witwatersrand, and National Research Foundation/Department of Science and Technology Research Chair in Vaccine Preventable Diseases. In January 2021, he was appointed Dean of the Faculty of Health Sciences at the University of the Witwatersrand.

<span class="mw-page-title-main">Sanofi–GSK COVID-19 vaccine</span> Vaccine candidate against COVID-19

The Sanofi–GSK COVID-19 vaccine sold under the brand name VidPrevtyn Beta, is a COVID-19 vaccine developed by Sanofi Pasteur and GSK.

Professor Patrick Francis Chinnery, FRCP, FRCPath, FMedSci, is a neurologist, clinician scientist, and Wellcome Trust Principal Research Fellow based in the Medical Research Council Mitochondrial Biology Unit and the University of Cambridge, where he is also Professor of Neurology and Head of the Department of Clinical Neurosciences.

<span class="mw-page-title-main">Csaba Szabo (pharmacologist)</span>

Csaba Szabo, a physician and pharmacologist, is the Head of the Pharmacology Section of the University of Fribourg in Switzerland. The Public Library of Science Magazine, PLOS Biology, recognized Szabo in 2019 as one of the most cited researchers in the world.

References

  1. 1 2 3 4 5 6 7 8 9 Anon (2017). "Vallance, Sir Patrick (John Thompson)" . Who's Who (online Oxford University Press  ed.). Oxford: A & C Black. doi:10.1093/ww/9780199540884.013.U246054.(Subscription or UK public library membership required.)
  2. 1 2 3 4 Vallance, Patrick (1997). "Exploring vascular nitric oxide in health and disease. The Goulstonian Lecture 1996". Journal of the Royal College of Physicians of London. 31 (3): 321–7. PMC   5421009 . PMID   9192338.
  3. ↑ "Natural History Museum appoints Patrick Vallance as chair". February 2022.
  4. ↑ Can Data Make a Medicine?, YouTube video, Royal Institution (2017)
  5. 1 2 3 Anon (2015). "Patrick Vallance: Inquisitive and geeky". British Medical Journal . 350 (mar05 5): h1144. doi:10.1136/bmj.h1144. ISSN   1756-1833. PMID   25742697. S2CID   5081180.(subscription required)
  6. 1 2 "Career profile; Patrick Vallance". St George's Alumni Newsletter; The magazine for Alumni and friends of St George’s, University of London. Issue 16 (spring 2013), p.18-19.
  7. ↑ Hardy, Jack (13 March 2020). "Who is Sir Patrick Vallance? Government's chief scientific adviser carved path through research and big pharma" . The Telegraph. ISSN   0307-1235. Archived from the original on 12 January 2022. Retrieved 18 March 2020.
  8. 1 2 Patrick Vallance publications indexed by the Scopus bibliographic database. (subscription required)
  9. 1 2 3 4 5 6 7 Anon (2017). "Patrick Vallance". royalsociety.org. London: Royal Society . Retrieved 19 March 2020.
  10. ↑ Moncada, Salvador (1999). "Nitric oxide: discovery and impact on clinical medicine". Journal of the Royal Society of Medicine . 92 (4): 164–169. doi:10.1177/014107689909200402. ISSN   0141-0768. PMC   1297136 . PMID   10450191 – via SAGE Journals.
  11. ↑ Blackman Daniel J.; Morris-Thurgood Jayne A.; Atherton John J.; Ellis Gethin R.; Anderson Richard A.; Cockcroft John R.; Frenneaux Michael P. (2000). "Endothelium-Derived Nitric Oxide Contributes to the Regulation of Venous Tone in Humans". Circulation. 101 (2): 165–170. doi: 10.1161/01.CIR.101.2.165 . PMID   10637204.
  12. ↑ Barba, Gianvincenzo; Mullen, Michael J.; Donald, Anne; MacAllister, Raymond J. (1999). "Determinants of the Response of Human Blood Vessels to Nitric Oxide Donors In Vivo". Journal of Pharmacology and Experimental Therapeutics. 289 (3): 1662–1668. ISSN   0022-3565. PMID   10336566.
  13. ↑ Morales-Ruiz, Manuel (2011). "14. Pathophysiological role of Akt and endothelial nitric oxidesynthase in cirrhosis". In Groszmann, R. J.; Bosch, J. (eds.). Portal Hypertension in the 21st Century: The proceedings of a symposium sponsored by Axcan Pharma Inc. and NicOx S.A., held in Montrél, Canada, April 2–4, 2004. Springer Science & Business Media. pp. 121–125. ISBN   978-94-007-1042-9.
  14. ↑ Ketteler, Markus; Ritz, Eberhard (1 September 2000). "Renal failure: A state of nitric oxide deficiency?". Kidney International. 58 (3): 1356–1357. doi: 10.1046/j.1523-1755.2000.00294.x . ISSN   0085-2538. PMID   10972702.
  15. ↑ Vallance, P.; Leone, A.; Calver, A.; Collier, J.; Moncada, S. (1992). "Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure". The Lancet . 339 (8793): 572–575. doi:10.1016/0140-6736(92)90865-Z. ISSN   0140-6736. PMID   1347093. S2CID   9790385. Closed Access logo transparent.svg
  16. ↑ Medicine, National Academies of Sciences, Engineering, and (2017). Real-World Evidence Generation and Evaluation of Therapeutics: Proceedings of a Workshop. National Academies Press. p. 74. ISBN   978-0-309-45565-7.{{cite book}}: CS1 maint: multiple names: authors list (link)
  17. ↑ Kafetz, Kalman (July 2005). "Integrated teams". Journal of the Royal Society of Medicine. 98 (7): 338. doi:10.1177/014107680509800725. ISSN   0141-0768. PMC   1168934 . PMID   15994605.
  18. ↑ Vallance, Patrick (2005). "A post-take ward round". Journal of the Royal Society of Medicine. 98 (5): 191–192. doi:10.1177/014107680509800503. ISSN   0141-0768. PMC   1129032 . PMID   15863758.
  19. ↑ Varughese, George I; Dissanayake, Sanjaya U (August 2005). "The working day in general medicine". Journal of the Royal Society of Medicine. 98 (8): 387. doi:10.1177/014107680509800827. ISSN   0141-0768. PMC   1181855 . PMID   16055914.
  20. ↑ Watts, Geoff (2007). "Working within industry's silken but firm embrace". British Medical Journal. 334 (7599): 871.1–871. doi:10.1136/bmj.39190.671644.DB. ISSN   0959-8138. PMC   1857744 . PMID   17463447.
  21. ↑ "Dr Patrick Vallance: President, R&D". gsk.com. Archived from the original on 29 July 2017.
  22. ↑ Jim Al-Khalili (2015). "The Life Scientific interviews Patrick Vallance on pharmaceuticals". bbc.co.uk. BBC.
  23. ↑ Cohen, Deborah (2012). "The End of Drug Discovery". bbc.co.uk. BBC.
  24. ↑ Anon (2010). "Patrick Vallance". Nature Reviews Drug Discovery . 9 (11): 834. doi: 10.1038/nrd3307 . ISSN   1474-1776. PMID   21030993. S2CID   11104458. Closed Access logo transparent.svg
  25. 1 2 Cressey, Daniel (2011). "Deep future of drug discovery". Nature. doi:10.1038/news.2011.127. ISSN   1744-7933.
  26. ↑ Rose, Nikolas (2018). OurPsychiatric Future. John Wiley & Sons. p. 130. ISBN   978-0-7456-8915-9.
  27. ↑ Cressey, Daniel (2011). "Traditional drug-discovery model ripe for reform". Nature . 471 (7336): 17–18. Bibcode:2011Natur.471...17C. doi:10.1038/471017a. ISSN   0028-0836. PMID   21368796. S2CID   4395455.
  28. ↑ Evanson, Deborah; Narcross, Jon (4 May 2016). "Imperial celebrates over 3,000 graduating students | Imperial News | Imperial College London". Imperial News. Retrieved 21 March 2020.
  29. ↑ Gibney, Elizabeth (2017). "U.K. Government Appoints Next Chief Scientific Adviser". Nature. 551 (7680): 282. Bibcode:2017Natur.551..282G. doi: 10.1038/nature.2017.22956 . PMID   29144475 . Retrieved 21 March 2020.
  30. ↑ "Appointment of Dr Patrick Vallance as government Chief Scientific Adviser". Cabinet Office. 8 November 2017. Retrieved 9 November 2017.
  31. ↑ "Patrick Vallance, President, R&D, GSK to become UK Government's Chief Scientific Adviser". GlaxoSmithKline. 8 November 2017. Retrieved 7 September 2018.
  32. ↑ Glasziou, Paul; Chalmers, Iain (2018). "Research waste is still a scandal". British Medical Journal. 363. doi:10.1136/bmj.k4645. ISSN   0959-8138. PMID   30420358. S2CID   53294156.
  33. ↑ Watts, Charlotte H.; Vallance, Patrick; Whitty, Christopher J. M. (2020). "Coronavirus: global solutions to prevent a pandemic". Nature. 578 (7795): 363. Bibcode:2020Natur.578R.363W. doi: 10.1038/d41586-020-00457-y . ISSN   0028-0836. PMID   32071448.
  34. ↑ "Government is listening to scientists on coronavirus response, Vallance says | Civil Service World". civilserviceworld.com. Retrieved 24 March 2020.
  35. ↑ Heather Stewart; Mattha Busby (13 March 2020). "Coronavirus: science chief defends UK plan from criticism". The Guardian. Retrieved 5 July 2020.
  36. ↑ Roach, April (24 September 2020). "Matt Hancock denies conflict of interest in Patrick Vallance holding vaccine company shares". Evening Standard. Retrieved 26 September 2020.
  37. ↑ Hymas, Charles (23 September 2020). "Revealed: Sir Patrick Vallance has £600,000 shareholding in firm contracted to develop vaccines" . The Daily Telegraph. Archived from the original on 12 January 2022. Retrieved 26 September 2020.
  38. ↑ Jimenez, Darcy (24 September 2020). "UK's chief scientific adviser Patrick Vallance has £600,000 of shares in vaccine maker GSK". Metro. Retrieved 26 September 2020.
  39. ↑ Press Association (6 November 2020). "Government criticised after errors emerge in key Covid-19 projections". Glasgow Times. Retrieved 7 November 2020.
  40. ↑ Conway, Ed (6 November 2020). "Coronavirus: Disturbing lack of transparency risks undermining lockdown". Sky News. Retrieved 7 November 2020.
  41. ↑ "Slides and datasets to accompany coronavirus press conference: 31 October 2020". GOV.UK. Prime Minister's Office. 3 November 2020. Retrieved 7 November 2020.
  42. ↑ "Covid: Regulator criticises data used to justify lockdown". BBC News. 5 November 2020. Retrieved 7 November 2020.
  43. ↑ "OSR Statement regarding transparency of data related to COVID-19". Office for Statistics Regulation. 5 November 2020. Retrieved 7 November 2020.
  44. ↑ Vallance, P.; Moncada, S. (1991). "Hyperdynamic circulation in cirrhosis: a role for nitric oxide?". The Lancet. 337 (8744): 776–778. doi:10.1016/0140-6736(91)91384-7. ISSN   0140-6736. PMID   1706450. S2CID   35521040.
  45. ↑ Collier, J; Vallance, P (1991). "Physiological importance of nitric oxide". BMJ. 302 (6788): 1289–1290. doi:10.1136/bmj.302.6788.1289. ISSN   0959-8138. PMC   1670035 . PMID   2059682.
  46. ↑ Vallance, Patrick (2002). "Nitric oxide in the human cardiovascular system-SKB lecture 1997". British Journal of Clinical Pharmacology. 45 (5): 433–439. doi:10.1046/j.1365-2125.1998.00720.x. ISSN   0306-5251. PMC   1873539 . PMID   9643614.
  47. ↑ Vallance, Patrick (1999). "Sildenafil: desired and undesired effects". Hospital Medicine. 60 (3): 158–159. doi:10.12968/hosp.1999.60.3.1057. ISSN   1462-3935. PMID   10476234.
  48. ↑ Donnelly, Christl A.; Boyd, Ian; Campbell, Philip; Craig, Claire; Vallance, Patrick; Walport, Mark; Whitty, Christopher J. M.; Woods, Emma; Wormald, Chris (2018). "Four principles to make evidence synthesis more useful for policy". Nature. 558 (7710): 361–364. Bibcode:2018Natur.558..361D. doi: 10.1038/d41586-018-05414-4 . hdl: 10044/1/61362 . ISSN   0028-0836. PMID   29925978.
  49. ↑ Spronk, Peter E; Zandstra, Durk F; Ince, Can (2004). "Bench-to-bedside review: Sepsis is a disease of the microcirculation". Critical Care. 8 (6): 462–468. doi: 10.1186/cc2894 . ISSN   1364-8535. PMC   1065042 . PMID   15566617.
  50. ↑ "Royal Academy of Engineering welcomes 72 new Fellows". Royal Academy of Engineering. Retrieved 26 September 2022.
  51. ↑ "Patrick Vallance knighted in 2019 New Year's Honours". British Pharmacological Society. 29 December 2018. Retrieved 7 February 2019.
  52. ↑ "No. 63571". The London Gazette (Supplement). 1 January 2022. p. N3.
  53. ↑ "New Year Honours: Whitty, Van-Tam and Blair knighted, Lumley and Redgrave made dames". BBC News. 31 December 2021. Retrieved 31 December 2021.
  54. ↑ Royal Medal 2023
  55. ↑ "Our Trustees". Cardboard Citizens. Retrieved 24 September 2020.
Business positions
Preceded by
 Head of R&D at GSK
January 2012 – March 2018		Succeeded by
Government offices
Preceded by
Chris Whitty
Acting
 Government Chief Scientific Adviser
2018–present		Incumbent
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.